
TY  - JOUR
TI  - Poster Abstracts
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 17
IS  - S3
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.14306
DO  - doi:10.1111/ajt.14306
SP  - 411
EP  - 815
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts—Symposia
JO  - Alcoholism: Clinical and Experimental Research
VL  - 36
IS  - s1
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.2012.01804.x
DO  - doi:10.1111/j.1530-0277.2012.01804.x
SP  - 304A
EP  - 369A
PY  - 2012
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Journal of Gastroenterology and Hepatology
JA  - J Gastroenterol Hepatol
VL  - 28
IS  - S3
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.12363_2
DO  - doi:10.1111/jgh.12363_2
SP  - 23
EP  - 693
PY  - 2013
ER  - 

TY  - JOUR
TI  - Spring Scientific Meeting 2010
JO  - International Endodontic Journal
VL  - 43
IS  - 9
SN  - 0143-2885
UR  - https://doi.org/10.1111/j.1365-2591.2010.01775.x
DO  - doi:10.1111/j.1365-2591.2010.01775.x
SP  - 828
EP  - 831
PY  - 2010
ER  - 

TY  - JOUR
TI  - Translational Science 2012 Meeting Abstracts
JO  - Clinical and Translational Science
VL  - 5
IS  - 2
SN  - 1752-8054
UR  - https://doi.org/10.1111/j.1752-8062.2012.00398.x
DO  - doi:10.1111/j.1752-8062.2012.00398.x
SP  - 141
EP  - 210
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts—Speakers
JO  - Alcoholism: Clinical and Experimental Research
JA  - Alcohol Clin Exp Res
VL  - 41
IS  - S1
SN  - 0145-6008
UR  - https://doi.org/10.1111/acer.13392
DO  - doi:10.1111/acer.13392
SP  - 265A
EP  - 338A
PY  - 2017
ER  - 

TY  - JOUR
AU  - Pape, A.
AU  - Kertscho, H.
AU  - Meier, J.
AU  - Zwissler, B.
AU  - Habler, O.
TI  - Overview of artificial O2 carriers
JO  - ISBT Science Series
VL  - 1
IS  - 1
SN  - 1751-2816
UR  - https://doi.org/10.1111/j.1751-2824.2006.00024.x
DO  - doi:10.1111/j.1751-2824.2006.00024.x
SP  - 152
EP  - 160
PY  - 2006
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Thrombosis and Haemostasis
VL  - 3
IS  - s1
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2005.0300c.x
DO  - doi:10.1111/j.1538-7836.2005.0300c.x
SP  - P0001
EP  - P2386
PY  - 2005
ER  - 

TY  - JOUR
AU  - Esper, Dema Halasa
AU  - Harb, Wael A.
TI  - The Cancer Cachexia Syndrome: A Review of Metabolic and Clinical Manifestations
JO  - Nutrition in Clinical Practice
JA  - Nutr Clin Pract
VL  - 20
IS  - 4
SN  - 0884-5336
UR  - https://doi.org/10.1177/0115426505020004369
DO  - doi:10.1177/0115426505020004369
SP  - 369
EP  - 376
PY  - 2005
AB  - The progressive deterioration in nutrition status frequently seen in cancer patients is often referred to as cancer cachexia. Unlike starvation, in which fat stores from adipose are depleted and protein is spared from skeletal muscle, neither fat nor protein is spared in cachexia. Cachexia affects nearly half of cancer patients, causing the clinical manifestations of anorexia, muscle wasting, weight loss, early satiety, fatigue, and impaired immune response. Cachexia does not only impede the response to chemotherapy but also is a major cause of morbidity and mortality. According to clinical studies, increasing caloric intake does not necessarily reverse cachexia. The pathophysiology of cachexia involves more complex mechanisms than simply caloric deficiency. The process appears to be mediated by circulating catabolic factors, either secreted by the tumor alone or in concert with host-derived factors, such as tumor necrosis factor-α (TNF-α), interleukins (IL-1 and IL-6), interferon (IFN-y), and leukemia inhibitory factor (LIF). The successful reversal of this process will require in-depth knowledge of the mechanisms involved, which will then enable the development of effective pharmacologic interventions that may not only improve quality of life, but more importantly, improve survival among cancer patients.
ER  - 

TY  - JOUR
TI  - Abstracts—Speakers
JO  - Alcoholism: Clinical and Experimental Research
JA  - Alcohol Clin Exp Re
VL  - 43
IS  - S1
SN  - 0145-6008
UR  - https://doi.org/10.1111/acer.14060
DO  - doi:10.1111/acer.14060
SP  - 259A
EP  - 333A
PY  - 2019
ER  - 

TY  - JOUR
TI  - 2014 Annual Meeting of the American Society for Bone and Mineral Research Houston, TX September 12–15, 2014
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 29
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.2476
DO  - doi:10.1002/jbmr.2476
SP  - S1
EP  - S1
PY  - 2014
AB  - ABSTRACT Searchable abstracts may be found at http://www.asbmr.org/education/abstracts
ER  - 

TY  - JOUR
TI  - Paper Abstract
JO  - Journal of the American Geriatrics Society
JA  - J Am Geriatr Soc
VL  - 62
IS  - s1
SN  - 0002-8614
UR  - https://doi.org/10.1111/jgs.12870
DO  - doi:10.1111/jgs.12870
SP  - S1
EP  - S331
PY  - 2014
ER  - 

TY  - JOUR
AU  - Pupelis, G.
AU  - Zeiza, K.
AU  - Plaudis, H.
AU  - Suhova, A.
TI  - Conservative approach in the management of severe acute pancreatitis: eight-year experience in a single institution
JO  - HPB
VL  - 10
IS  - 5
SN  - 1365-182X
UR  - https://doi.org/10.1080/13651820802140737
DO  - doi:10.1080/13651820802140737
SP  - 347
EP  - 355
KW  - SAP
KW  - conservative approach
KW  - reduced infection
KW  - reduced mortality
PY  - 2008
AB  - Abstract Introduction. Recognition of severe acute pancreatitis (SAP), intensive care, shifting away from early surgical treatment, and monitoring of the intra-abdominal pressure (IAP) is important in the management of SAP. The aim of our study was retrospective evaluation and critical assessment of the experience with SAP management protocol involving new strategy in the university hospital. Methods. Protocols of 274 SAP patients treated in our institution during the last eight years were reassessed. APACHE II, CRP and SOFA score, IAP, pulmonary complications, ventilatory support and infection rate were evaluated. The success of the conservative treatment, surgical interventions and mortality was analysed comparing period 1 from 1999 to 2002 and period 2 from 2003 to 2006. Results. More patients with necrotising SAP were treated in period 2. The average CRP and SOFA score was higher in period 2, p=0.018; p=0.011. A total of 139 patients underwent continuous veno-venouse haemofiltration (CVVH) as a component of fluid resuscitation and IAP control. Application of CVVH increased in period 2, p<0.005. Only 5?8% of patients were managed with ventilatory support. The overall infection rate decreased in period 2 comprising 21%, p<0.005. Success rate of the conservative therapy reached 69% in period 2, p<0.01. Surgical treatment was performed in 41% of patients in period 1 vs. 19% in period 2, p<0.001. Overall mortality was 19%, with a reduction to 12% in year 2006. Conclusion. The conservative protocol-based approach is a rational treatment strategy for the management of SAP and can be successfully implemented in the setting of the university hospital.
ER  - 

TY  - JOUR
TI  - Posters (Abstracts 289–2348)
JO  - Hepatology
JA  - Hepatology
VL  - 70
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.30941
DO  - doi:10.1002/hep.30941
SP  - 188
EP  - 1382
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Epilepsia
VL  - 43
IS  - S8
SN  - 0013-9580
UR  - https://doi.org/10.1111/j.1528-1167.2002.tb06320.x
DO  - doi:10.1111/j.1528-1167.2002.tb06320.x
SP  - 65
EP  - 207
PY  - 2002
ER  - 

TY  - JOUR
TI  - Posters
JO  - Clinical Microbiology and Infection
VL  - 13
IS  - s1
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2007.01733.x
DO  - doi:10.1111/j.1469-0691.2007.01733.x
SP  - S109
EP  - S608
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - The FEBS Journal
JA  - FEBS J
VL  - 281
IS  - s1
SN  - 1742-464X
UR  - https://doi.org/10.1111/febs.12919
DO  - doi:10.1111/febs.12919
SP  - 65
EP  - 784
PY  - 2014
ER  - 

C7  - pp. 1.1-1.84
TI  - Index
SN  - 9781555818807
UR  - https://doi.org/10.1128/9781555818814.index
DO  - doi:10.1128/9781555818814.index
SP  - 1.1-1.84
PY  - 2014
ER  - 

TY  - JOUR
TI  - Concurrent Sessions Posters
JO  - HPB
JA  - HPB
VL  - 15
IS  - s2
SN  - 9781555818807
UR  - https://doi.org/10.1111/hpb.12093
DO  - doi:10.1111/hpb.12093
SP  - 85
EP  - 244
PY  - 2013
ER  - 

TY  - JOUR
AU  - American Society for Parenteral and Enteral Nutrition
TI  - Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients
JO  - Journal of Parenteral and Enteral Nutrition
JA  - Journal of Parenteral and Enteral Nutrition
VL  - 26
IS  - 1S
SN  - 9781555818807
UR  - https://doi.org/10.1177/0148607102026001011
DO  - doi:10.1177/0148607102026001011
SP  - 1SA
EP  - 138SA
PY  - 2002
ER  - 
